| Client/Parent | Total |
|---|---|
| Pharmaceutical Research & Manufacturers of America |  $22,772,000 |
| Biotechnology Innovation Organization | $9,090,000 |
| Pfizer Inc | $8,700,000 |
| Amgen Inc | $8,540,000 |
| Roche Holdings | $8,355,000 |
2019-2020
$725,442 $723,947 $582,018 $563,944 $486,126 $439,353 $435,740 $422,281 $380,397 $374,175 $313,900 $274,201 $257,049 $251,251 $250,000 $234,047 $228,515 $209,936 $206,219 $202,626
Contributions to:
Democrats
Republicans
Liberal Groups
Conservative Groups
Nonpartisan
Democrats
Republicans
Liberal Groups
Conservative Groups
Nonpartisan
Top Recipients, 2019-2020
| Candidate | Office | Amount |
|---|---|---|
| Buttigieg, Pete (D) | $253,792 | |
| McConnell, Mitch (R-KY) | Senate | $249,486 |
| McCarthy, Kevin (R-CA) | House | $221,300 |
| Sanders, Bernie (D) | Senate | $199,014 |
| Tillis, Thom (R-NC) | Senate | $180,273 |
https://www.opensecrets.org/industries/indus.php?ind=H04
...........................................................................
...........................................................................
7-19-18 Big Pharma’s top eleven corporations generated net profits in just one decade from 2003 to 2012 of nearly three quarters of a trillion dollars – that’s just net profit alone. The net profit for 2012 amongst those top eleven amounted to $85 billion in just that one year. The majority of these largest pharmaceuticals are headquartered in the US – including the top four, Johnson & Johnson (#39 on Fortune 500 list), Pfizer (#51), Merck (#65) and Eli Lilly (#129) along with Abbott (#152) and Bristol Myers Squibb (#176). The healthcare research company IMS Health projects worldwide sales of Pharma drugs to exceed one trillion dollars by 2014….Big Pharma poured $2.7 billion into its lobbying interests from 1998 to 2013, 42% more than the second most “Gov. Corp.” bribe which happens to be its sister industry insurance.
And it’s this unholy trinity of the medical establishment (personified by the American Medical Association), embedded insurance industry that wrote Obamacare into law and Big Pharma that makes the United States the most costly, broken, corrupt, destructive healthcare system in the entire world. The structured system is designed and layered with built-in incentives at every tier to make and keep people sick, chronically dependent on their drugs for survival that merely mask and smother symptoms rather than cure or eradicate the root cause of disease….
Even more alarming is the fact that death by medical error at near a quarter million people annually has become the third largest killer of US citizens behind heart disease and cancer. Other more recent studies have estimated upwards of up to 440,000 have died yearly from preventable mistakes at hospitals. Blind obedience to Big Pharma and a conventional medical system too dependent on surgery and technology has inflicted more harm than good on the U.S. population. https://www.globalresearch.ca/the-evils-of-big-pharma-exposed/5425382
………….........................
1-15-19 And herein lies the fundamental problem. There are more doctors, more hospitals, more pharmaceutical drugs and medical procedures than ever before and yet we have not conquered nor made any significant progress in curing any major disease. Instead of making efforts to fund disease prevention and educate the public, prevention has been abandoned altogether. https://prn.fm/corruption-science-leads-collapse-modern-civilization/
………........................................
9-27-19 There are three key provisions in the intellectual property rights chapter of the renegotiated NAFTA that would also be incorporated into any free-trade pact with India, all of which would prove to be a major coup for American pharmaceutical profiteering. First, patents would be granted for all innovations, including new methods, uses and processes of using a known product. That alone would represent a major overhaul of the Indian Patents Act, which only provides patents if the innovations prove therapeutic efficacy. https://readsludge.com/2019/09/27/trump-poised-to-give-big-pharma-a-big-present-in-india-trade-deal/
…………….
Table 1. Top U.S. Drug Advertisement Expenditures (2016) 9
Drug/Maker
Advertisement
(in USD millions)
Purpose
Humira/AbbVie
$439
Anti-inflammatory
Lyrica/Pfizer
$392
Nerve pain management
Eliquis/Bristol-Myers Squibb
$296
Blood thinner
Xeljanz/Pfizer
$258
Anti-inflammatory
Opdivo/Bristol-Myers Squibb
$168
Cancer treatment
Chantix/Pfizer
$151
Smoking cessation
Cialis/Lilly
$150
Erectile dysfunction
Trulicity/Lilly
$142
Increase glucose (diabetes)
Prevnar/Pfizer
$142
Pneumonia vaccine
The pharmaceutical industry spends hundreds of millions of dollars annually to market its products. Direct-to-consumer prescription ads are the second-fastest growing ad category, competing with other top marketers stemming from automotive, fast food, insurance, and cable/wireless providers. 10, 11 Ad spending for television by pharmaceutical companies has more than doubled in the last four years, representing a 65% increase in this genre since 2012. http://law.emory.edu/ecgar/content/volume-5/issue-2/essays/thieves-pharma-power-help-government-regulation.html.
No comments:
Post a Comment